Allegra Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Allegra, and when can generic versions of Allegra launch?
Allegra is a drug marketed by Chattem Sanofi and is included in five NDAs.
The generic ingredient in ALLEGRA is fexofenadine hydrochloride; pseudoephedrine hydrochloride. There are twenty-three drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the fexofenadine hydrochloride; pseudoephedrine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Allegra
A generic version of Allegra was approved as fexofenadine hydrochloride; pseudoephedrine hydrochloride by DR REDDYS LABS LTD on June 22nd, 2011.
Summary for Allegra
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 224 |
Clinical Trials: | 35 |
Patent Applications: | 4,349 |
Formulation / Manufacturing: | see details |
Drug Sales Revenues: | Drug sales revenues for Allegra |
DailyMed Link: | Allegra at DailyMed |
Recent Clinical Trials for Allegra
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of California, San Francisco | Early Phase 1 |
Food and Drug Administration (FDA) | Early Phase 1 |
University of Alabama at Birmingham | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for Allegra
US Patents and Regulatory Information for Allegra
Expired US Patents for Allegra
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Chattem Sanofi | ALLEGRA | fexofenadine hydrochloride | CAPSULE;ORAL | 020625-001 | Jul 25, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
Chattem Sanofi | ALLEGRA | fexofenadine hydrochloride | CAPSULE;ORAL | 020625-001 | Jul 25, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
Chattem Sanofi | ALLEGRA | fexofenadine hydrochloride | CAPSULE;ORAL | 020625-001 | Jul 25, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
Chattem Sanofi | ALLEGRA | fexofenadine hydrochloride | CAPSULE;ORAL | 020625-001 | Jul 25, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Allegra
See the table below for patents covering Allegra around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
New Zealand | 285229 | 4-(BIPHENYLMETHYL)PIPERDINE DERIVATIVES IN ANHYDROUS AND HYDRATED FORMS, THEIR PREPARATION AND MEDICAMENTS THEREOF | ⤷ Try a Trial |
Israel | 134771 | PHARMACEUTICAL COMPOSITIONS OF PIPERIDINOALKANOL COMPOUNDS IN SOLID UNIT DOSAGE FORM | ⤷ Try a Trial |
Australia | 5501880 | ⤷ Try a Trial | |
Israel | 59158 | 4-SUBSTITUTED PIPERIDINOALKANOLS,THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |